TAK-771-4002: Evaluating the Safety of GAMMAGARD LIQUID for the Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

ENCePP Code of conduct

No

Data sources

• Data source(s), other:
  IBM MarketScan Research Databases United States, Optum Clinformatics Data Mart United States
• Data sources (types):
  Administrative data (e.g. claims)

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No